{
    "Symbol": "DXCM",
    "AssetType": "Common Stock",
    "Name": "DexCom Inc",
    "Description": "DexCom, Inc. is a company that develops, manufactures, and distributes continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with headquarters in San Diego, California, and has a manufacturing facility in Mesa, Arizona.",
    "CIK": "1093557",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "SURGICAL & MEDICAL INSTRUMENTS & APPARATUS",
    "Address": "6340 SEQUENCE DRIVE, SAN DIEGO, CA, US",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2022-12-31",
    "MarketCapitalization": "42895819000",
    "EBITDA": "530700000",
    "PERatio": "135.38",
    "PEGRatio": "11.34",
    "BookValue": "5.52",
    "DividendPerShare": "0",
    "DividendYield": "0",
    "EPS": "0.82",
    "RevenuePerShareTTM": "7.47",
    "ProfitMargin": "0.117",
    "OperatingMarginTTM": "0.134",
    "ReturnOnAssetsTTM": "0.0474",
    "ReturnOnEquityTTM": "0.164",
    "RevenueTTM": "2909800000",
    "GrossProfitTTM": "1883100000",
    "DilutedEPSTTM": "0.82",
    "QuarterlyEarningsGrowthYOY": "0.166",
    "QuarterlyRevenueGrowthYOY": "0.168",
    "AnalystTargetPrice": "132.22",
    "TrailingPE": "135.38",
    "ForwardPE": "120.48",
    "PriceToSalesRatioTTM": "16.54",
    "PriceToBookRatio": "24.66",
    "EVToRevenue": "16.02",
    "EVToEBITDA": "103.12",
    "Beta": "1.108",
    "52WeekHigh": "134.76",
    "52WeekLow": "66.89",
    "50DayMovingAverage": "111.14",
    "200DayMovingAverage": "95.76",
    "SharesOutstanding": "386414000",
    "DividendDate": "None",
    "ExDividendDate": "None"
}